Username


Password

Preview

Michael Gossop

Publications

  • TOP 3
  • Anne Bukten; Svetlana Skurtveit; Michael Gossop; Helge Waal; Per Stangeland; Ingrid Havnes; Thomas Clausen
    Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study.
  • John-Kåre Vederhus; Oistein Kristensen; Thomas Clausen; Michael Gossop
    Turn something bad into something good.
  • Marie Jauffret-Roustide; Julien Cohen; Isabelle Poisot-Martin; Bruno Spire; Michael Gossop; M Patrizia Carrieri;
    Distributive sharing among HIV-HCV co-infected injecting drug users: the preventive role of trust in one's physician.
Register to see all publications

Register for free to view:

Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the research activity
of experts around the globe
Register to see more

Geonetwork of Michael Gossop (preview)

  • Cities where this author has publications
  • Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

  • 2012: Anne Bukten; Svetlana Skurtveit; Michael Gossop; Helge Waal; Per Stangeland; Ingrid Havnes; Thomas Clausen
    Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study.
    Addiction (Abingdon, England) 2012;107(2):393-9.
  • 2012: John-Kåre Vederhus; Oistein Kristensen; Thomas Clausen; Michael Gossop
    Turn something bad into something good.
    The British journal of general practice : the journal of the Royal College of General Practitioners 2012;62(594):32.
  • 2012: Marie Jauffret-Roustide; Julien Cohen; Isabelle Poisot-Martin; Bruno Spire; Michael Gossop; M Patrizia Carrieri;
    Distributive sharing among HIV-HCV co-infected injecting drug users: the preventive role of trust in one's physician.
    AIDS care 2012;24(2):232-8.
  • 2011: Anne Bukten; Svetlana Skurtveit; Per Stangeland; Michael Gossop; Astrid B Willersrud; Helge Waal; Ingrid Havnes; Thomas Clausen
    Criminal convictions among dependent heroin users during a 3-year period prior to opioid maintenance treatment: a longitudinal national cohort study.
    Journal of substance abuse treatment 2011;41(4):407-14.
  • 2011: Soraya Mayet; Michael Gossop; Nicholas Lintzeris; Vias Markides; John Strang
    Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Drug and alcohol review 2011;30(4):388-96.
  • 2011: Jon Mordal; Bjørn Holm; Michael Gossop; Maria Romøren; Jørg Mørland; Jørgen G Bramness
    Psychoactive substance use among patients admitted to an acute psychiatric ward: laboratory findings and associations with clinical characteristics.
    Nordic journal of psychiatry 2011;65(3):208-15.
  • 2011: Perrine Roux; Patrizia M Carrieri; Julien Cohen; Isabelle Ravaux; Bruno Spire; Michael Gossop; Sandra D Comer
    Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: the need for a more comprehensive approach.
    Harm reduction journal 2011;8():31.
  • 2011: Ivar Skeie; Mette Brekke; Michael Gossop; Morten Lindbaek; Even Reinertsen; Magne Thoresen; Helge Waal
    Changes in somatic disease incidents during opioid maintenance treatment: results from a Norwegian cohort study.
    BMJ open 2011;1(1):e000130.
  • 2010: Katinka Anchersen; Viggo Hansteen; Michael Gossop; Thomas Clausen; Helge Waal
    Opioid maintenance patients with QTc prolongation: congenital long QT syndrome mutation may be a contributing risk factor.
    Drug and alcohol dependence 2010;112(3):216-9.
  • 2010: Nikolaj Kunøe; Philipp Lobmaier; John Kåre Vederhus; Bjørg Hjerkinn; Michael Gossop; Solfrid Hegstad; Øistein Kristensen; Helge Waal
    Challenges to antagonist blockade during sustained-release naltrexone treatment.
    Addiction (Abingdon, England) 2010;105(9):1633-9.
  • 2010: Nikolaj Kunøe; Philipp Lobmaier; John Kåre Vederhus; Bjørg Hjerkinn; Solfrid Hegstad; Michael Gossop; Oistein Kristensen; Helge Waal
    Retention in naltrexone implant treatment for opioid dependence.
    Drug and alcohol dependence 2010;111(1-2):166-9.
  • 2010: Philipp Lobmaier; Michael Gossop; Helge Waal; Jorgen Bramness
    The pharmacological treatment of opioid addiction--a clinical perspective.
    European journal of clinical pharmacology 2010;66(6):537-45.
  • 2010: Vincent Chin-Hung Chen; Tsang-Yaw Lin; Charles Tzu-Chi Lee; Te-Jen Lai; Hong Chen; Cleusa P Ferri; Michael Gossop
    Suicide attempts prior to starting methadone maintenance treatment in Taiwan.
    Drug and alcohol dependence 2010;109(1-3):139-43.
  • 2010: Linn Gjersing; Helge Waal; John R M Caplehorn; Michael Gossop; Thomas Clausen
    Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment.
    BMC health services research 2010;10():194.
  • 2010: Philipp P Lobmaier; Nikolaj Kunøe; Michael Gossop; Tormod Katevoll; Helge Waal
    Naltrexone implants compared to methadone: outcomes six months after prison release.
    European addiction research 2010;16(3):139-45.
  • 2009: Michael Gossop
    Review: limited evidence to support pharmacological therapy for amphetamine withdrawal.
    Evidence-based mental health 2009;12(4):122.
  • 2009: Victoria Manning; Shai Betteridge; Shamil Wanigaratne; David Best; John Strang; Michael Gossop
    Cognitive impairment in dual diagnosis inpatients with schizophrenia and alcohol use disorder.
    Schizophrenia research 2009;114(1-3):98-104.
  • 2009: Thomas Clausen; Helge Waal; Magne Thoresen; Michael Gossop
    Mortality among opiate users: opioid maintenance therapy, age and causes of death.
    Addiction (Abingdon, England) 2009;104(8):1356-62.
  • 2009: Gayle Ridge; Michael Gossop; Nicholas Lintzeris; John Witton; John Strang
    Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Journal of substance abuse treatment 2009;37(1):95-100.
  • 2009: Nikolaj Kunøe; Philipp Lobmaier; John Kåre Vederhus; Bjørg Hjerkinn; Solfrid Hegstad; Michael Gossop; Øistein Kristensen; Helge Waal
    Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial.
    The British journal of psychiatry : the journal of mental science 2009;194(6):541-6.
  • 2009: Katinka Anchersen; Thomas Clausen; Michael Gossop; Viggo Hansteen; Helge Waal
    Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
    Addiction (Abingdon, England) 2009;104(6):993-9.
  • 2009: Jennifer Bearn; Anshul Swami; Duncan Stewart; Catherine Atnas; Lisa Giotto; Michael Gossop
    Auricular acupuncture as an adjunct to opiate detoxification treatment: effects on withdrawal symptoms.
    Journal of substance abuse treatment 2009;36(3):345-9.
  • 2008: Vincent Chin-Hung Chen; Hong Chen; Tsang-Yaw Lin; Hwey-Hwang Chou; Te-Jen Lai; Cleusa P Ferri; Michael Gossop
    Severity of heroin dependence in Taiwan: reliability and validity of the Chinese version of the Severity of Dependence Scale (SDS[Ch]).
    Addictive behaviors 2008;33(12):1590-3.
  • 2008: Michael Gossop
    Maintenance treatments across countries.
    Addiction (Abingdon, England) 2008;103(9):1493-4.
  • 2008: Michael Gossop; Rudolf Moos
    Substance misuse among older adults: a neglected but treatable problem.
    Addiction (Abingdon, England) 2008;103(3):347-8.
  • 2008: V Manning; S Wanigaratne; D Best; R G Hill; L J Reed; D Ball; J Marshall; M Gossop; J Strang
    Changes in neuropsychological functioning during alcohol detoxification.
    European addiction research 2008;14(4):226-33.
  • 2008: Michael Gossop
    The clinical fallacy and treatment outcomes.
    Addiction (Abingdon, England) 2008;103(1):89-90.
  • 2008: Michael Gossop; Duncan Stewart; John Marsden
    Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study.
    Addiction (Abingdon, England) 2008;103(1):119-25.
  • 2008: Anthony Glasper; Michael Gossop; Cornelis de Wet; Laurence Reed; Jennifer Bearn
    Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
    Pharmacology 2008;81(2):92-6.
  • 2007: Duncan Stewart; Michael Gossop; Katia Trakada
    Drug dependent parents: childcare responsibilities, involvement with treatment services, and treatment outcomes.
    Addictive behaviors 2007;32(8):1657-68.
  • 2007: Michael Gossop; Domingos Neto; Mirjana Radovanovic; Anil Batra; Sonya Toteva; Michael Musalek; Arvid Skutle; Cees Goos
    Physical health problems among patients seeking treatment for alcohol use disorders: a study in six European cities.
    Addiction biology 2007;12(2):190-6.
  • 2007: J McCambridge; M Gossop; T Beswick; D Best; J Bearn; S Rees; J Strang
    In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    Drug and alcohol dependence 2007;88(1):91-5.
  • 2007: Laurence J Reed; Anthony Glasper; Cornelis J de Wet; Jennifer Bearn; Michael Gossop
    Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Journal of clinical psychopharmacology 2007;27(2):188-92.
  • 2007: Victoria Manning; Shamil Wanigaratne; David Best; Geraldine Strathdee; Isabella Schrover; Michael Gossop
    Screening for cognitive functioning in psychiatric outpatients with schizophrenia, alcohol dependence, and dual diagnosis.
    Schizophrenia research 2007;91(1-3):151-8.
  • 2007: Michael Gossop; Duncan Stewart; John Marsden
    Readiness for change and drug use outcomes after treatment.
    Addiction (Abingdon, England) 2007;102(2):301-8.
  • 2007: John E Helzer; Kathleen K Bucholz; Michael Gossop
    A dimensional option for the diagnosis of substance dependence in DSM-V.
    International journal of methods in psychiatric research 2007;16 Suppl 1():S24-33.
  • 2006: Michael Gossop; John Marsden; Duncan Stewart
    Remission of psychiatric symptoms among drug misusers after drug dependence treatment.
    The Journal of nervous and mental disease 2006;194(11):826-32.
  • 2006: Michael Gossop; Victoria Manning; Gayle Ridge
    Concurrent use and order of use of cocaine and alcohol: behavioural differences between users of crack cocaine and cocaine powder.
    Addiction (Abingdon, England) 2006;101(9):1292-8.
  • 2006: Michael Gossop
    Classification of illegal and harmful drugs.
    BMJ (Clinical research ed.) 2006;333(7562):272-3.
  • 2006: John Strang; Michael Gossop; Joan Heuston; John Green; Christopher Whiteley; Anthony Maden
    Persistence of drug use during imprisonment: relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine and amphetamine in prison.
    Addiction (Abingdon, England) 2006;101(8):1125-32.
  • 2006: David Best; Victoria Manning; Michael Gossop; Samantha Gross; John Strang
    Excessive drinking and other problem behaviours among 14-16 year old schoolchildren.
    Addictive behaviors 2006;31(8):1424-35.
  • 2006: Michael Gossop; Duncan Stewart; John Marsden
    Effectiveness of drug and alcohol counselling during methadone treatment: content, frequency, and duration of counselling and association with substance use outcomes.
    Addiction (Abingdon, England) 2006;101(3):404-12.
  • 2006: Michael Gossop; Kathleen M Carroll
    Disulfiram, cocaine, and alcohol: two outcomes for the price of one?
    Alcohol and alcoholism (Oxford, Oxfordshire) 2006;41(2):119-20.
  • 2006: Michael Gossop; Victoria Manning; Gayle Ridge
    Concurrent use of alcohol and cocaine: differences in patterns of use and problems among users of crack cocaine and cocaine powder.
    Alcohol and alcoholism (Oxford, Oxfordshire) 2006;41(2):121-5.
  • 2005: David Best; Samantha Gross; Victoria Manning; Michael Gossop; John Witton; John Strang
    Cannabis use in adolescents: the impact of risk and protective factors and social functioning.
    Drug and alcohol review 2005;24(6):483-8.
  • 2005: Christian Haasen; Michael Prinzleve; Michael Gossop; Gabriele Fischer; Miguel Casas
    Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users.
    World psychiatry : official journal of the World Psychiatric Association (WPA) 2005;4(3):173-6.
  • 2005: Michael Gossop; Katia Trakada; Duncan Stewart; John Witton
    Reductions in criminal convictions after addiction treatment: 5-year follow-up.
    Drug and alcohol dependence 2005;79(3):295-302.
  • 2005: Michael Gossop
    More panic in needle park.
    Addiction (Abingdon, England) 2005;100(7):922-3; discussion 930-2.
  • 2005: A Glasper; L J Reed; C J de Wet; M Gossop; J Bearn
    Induction of patients with moderately severe methadone dependence onto buprenorphine.
    Addiction biology 2005;10(2):149-55.
  • 2005: Michael Gossop; Francis Keaney; Pankaj Sharma; Mark Jackson
    The unique role of diamorphine in British medical practice: a survey of general practitioners and hospital doctors.
    European addiction research 2005;11(2):76-82.
  • 2004: Duncan Stewart; Michael Gossop; John Marsden
    Increased caseloads in methadone treatment programs: implications for the delivery of services and retention in treatment.
    Journal of substance abuse treatment 2004;27(4):301-6.
  • 2004: Cornelis de Wet; Laurence Reed; Anthony Glasper; Paul Moran; Jennifer Bearn; Michael Gossop
    Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome.
    Drug and alcohol dependence 2004;76(1):31-5.
  • 2004: Michael Gossop; Duncan Stewart; John Marsden; Tara Kidd; John Strang
    Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment.
    Addictive behaviors 2004;29(6):1085-94.
  • 2004: Christine Godfrey; Duncan Stewart; Michael Gossop
    Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS).
    Addiction (Abingdon, England) 2004;99(6):697-707.
  • 2004: Cleusa P Ferri; John Dunn; Michael Gossop; Ronaldo Laranjeira
    Factors associated with adverse reactions to cocaine among a sample of long-term, high-dose users in São Paulo, Brazil.
    Addictive behaviors 2004;29(2):365-74.
  • 2004: Michael Prinzleve; Christian Haasen; Heike Zurhold; Josep Lluis Matali; Eugeni Bruguera; József Gerevich; Erika Bácskai; Niamh Ryder; Shane Butler; Victoria Manning; et al.
    Cocaine use in Europe - a multi-centre study: patterns of use in different groups.
    European addiction research 2004;10(4):147-55.
  • 2004: Christian Haasen; Michael Prinzleve; Heike Zurhold; Juergen Rehm; Franziska Güttinger; Gabriele Fischer; Reinhold Jagsch; Börje Olsson; Mats Ekendahl; Annette Verster; et al.
    Cocaine use in Europe - a multi-centre study. Methodology and prevalence estimates.
    European addiction research 2004;10(4):139-46.
  • 2004: Lan-Ho Man; David Best; Michael Gossop; Garry Stillwell; John Strang
    Relationship between prescribing and risk of opiate overdose among drug users in and out of maintenance treatment.
    European addiction research 2004;10(1):35-40.
  • 2003: Michael Gossop; Nadine Browne; Duncan Stewart; John Marsden
    Alcohol use outcomes and heavy drinking at 4-5 years among a treatment sample of drug misusers.
    Journal of substance abuse treatment 2003;25(3):135-43.
  • 2003: Michael Gossop; Jennifer Harris; David Best; Lan-Ho Man; Victoria Manning; Jane Marshall; John Strang
    Is attendance at Alcoholics Anonymous meetings after inpatient treatment related to improved outcomes? A 6-month follow-up study.
    Alcohol and alcoholism (Oxford, Oxfordshire) 2003;38(5):421-6.
  • 2003: Michael Gossop; Duncan Stewart; John Marsden
    Treatment process components and heroin use outcome among methadone patients.
    Drug and alcohol dependence 2003;71(1):93-102.
  • 2003: Tracy Beswick; David Best; Jenny Bearn; Michael Gossop; Sian Rees; John Strang
    The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial.
    The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2003;12(4):295-305.
  • 2003: Andrew Healey; Martin Knapp; John Marsden; Michael Gossop; Duncan Stewart
    Criminal outcomes and costs of treatment services for injecting and non-injecting heroin users: evidence from a national prospective cohort survey.
    Journal of health services research & policy 2003;8(3):134-41.
  • 2003: Ian P Albery; Joan Heuston; Jane Ward; Paramabandhu Groves; Mary Alison Durand; Michael Gossop; John Strang
    Measuring therapeutic attitude among drug workers.
    Addictive behaviors 2003;28(5):995-1005.
  • 2003: Michael Gossop; Duncan Stewart; Nadine Browne; John Marsden
    Methadone treatment for opiate dependent patients in general practice and specialist clinic settings: Outcomes at 2-year follow-up.
    Journal of substance abuse treatment 2003;24(4):313-21.
  • 2003: Michael Gossop; John Marsden; Duncan Stewart; Tara Kidd
    Reduction or cessation of injecting risk behaviours? Treatment outcomes at 1-year follow-up.
    Addictive behaviors 2003;28(4):785-93.
  • 2003: John Strang; Jim McCambridge; David Best; Tracy Beswick; Jenny Bearn; Sian Rees; Michael Gossop
    Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study.
    BMJ (Clinical research ed.) 2003;326(7396):959-60.
  • 2003: David Best; Rosa Hernando; Michael Gossop; Clare Sidwell; John Strang
    Getting by with a little help from your friends: the impact of peer networks on criminality in a cohort of treatment-seeking drug users.
    Addictive behaviors 2003;28(3):597-603.
  • 2003: Tracy Beswick; David Best; Sian Rees; Jenny Bearn; Michael Gossop; John Strang
    Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatments.
    Addiction biology 2003;8(1):49-57.
  • 2003: Duncan Stewart; Michael Gossop; John Marsden; Tara Kidd; Samantha Treacy
    Similarities in outcomes for men and women after drug misuse treatment: results from the National Treatment Outcome Research Study (NTORS).
    Drug and alcohol review 2003;22(1):35-41.
  • 2003: Jennifer Harris; David Best; Michael Gossop; Jane Marshall; Lan-Ho Man; Victoria Manning; John Strang
    Prior Alcoholics Anonymous (AA) affiliation and the acceptability of the Twelve Steps to patients entering UK statutory addiction treatment.
    Journal of studies on alcohol 2003;64(2):257-61.
  • 2003: Michael Gossop; John Marsden; Duncan Stewart; Tara Kidd
    The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results.
    Addiction (Abingdon, England) 2003;98(3):291-303.
  • 2002: Michael Gossop; Duncan Stewart; Nadine Browne; John Marsden
    Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses.
    Addiction (Abingdon, England) 2002;97(10):1259-67.
  • 2002: David Best; Michael Gossop; Lan-Ho Man; Garry Stillwell; Ross Coomber; John Strang
    Peer overdose resuscitation: multiple intervention strategies and time to response by drug users who witness overdose.
    Drug and alcohol review 2002;21(3):269-74.
  • 2002: Alison Noble; David Best; Lan-Ho Man; Michael Gossop; John Stang
    Self-detoxification attempts among methadone maintenance patients: what methods and what success?
    Addictive behaviors 2002;27(4):575-84.
  • 2002: Cleusa P Ferri; Michael Gossop; Sophia Rabe-Hesketh; Ronaldo R Laranjeira
    Differences in factors associated with first treatment entry and treatment re-entry among cocaine users.
    Addiction (Abingdon, England) 2002;97(7):825-32.
  • 2002: Jennifer Bearn; Renu Gupta; Duncan Stewart; Judie English; Michael Gossop
    Sulphatoxymelatonin excretion during opiate withdrawal: a preliminary study.
    Progress in neuro-psychopharmacology & biological psychiatry 2002;26(4):677-81.
  • 2002: Michael Gossop; John Marsden; Duncan Stewart; Tara Kidd
    Changes in use of crack cocaine after drug misuse treatment: 4-5 year follow-up results from the National Treatment Outcome Research Study (NTORS).
    Drug and alcohol dependence 2002;66(1):21-8.
  • 2002: Michael Gossop; John Marsden; Duncan Stewart; Samantha Treacy
    Change and stability of change after treatment of drug misuse: 2-year outcomes from the National Treatment Outcome Research Study (UK).
    Addictive behaviors 2002;27(2):155-66.
  • 2002: Michael Gossop; John Marsden; Duncan Stewart
    Dual dependence: assessment of dependence upon alcohol and illicit drugs, and the relationship of alcohol dependence among drug misusers to patterns of drinking, illicit drug use and health problems.
    Addiction (Abingdon, England) 2002;97(2):169-78.
  • 2002: M Gossop; J Marsden; D Stewart; S Treacy
    Reduced injection risk and sexual risk behaviours after drug misuse treatment: results from the National Treatment Outcome Research Study.
    AIDS care 2002;14(1):77-93.
  • 2002: David Best; Alison Noble; Gayle Ridge; Michael Gossop; Michael Farrell; John Strang
    The relative impact of waiting time and treatment entry on drug and alcohol use.
    Addiction biology 2002;7(1):67-74.
  • 2002: Michael Gossop; Francis Keaney; Duncan Stewart; E Jane Marshall; John Strang
    A Short Alcohol Withdrawal Scale (SAWS): development and psychometric properties.
    Addiction biology 2002;7(1):37-43.
  • 2002: Michael Gossop; Duncan Stewart; Samantha Treacy; John Marsden
    A prospective study of mortality among drug misusers during a 4-year period after seeking treatment.
    Addiction (Abingdon, England) 2002;97(1):39-47.
  • 2002: Duncan Stewart; Michael Gossop; John Marsden
    Reductions in non-fatal overdose after drug misuse treatment: results from the National Treatment Outcome Research Study (NTORS).
    Journal of substance abuse treatment 2002;22(1):1-9.
  • 2001: F Keaney; J Strang; M Gossop; E J Marshall; M Farrell; S Welch; B Hahn; A Gonzalez
    A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: lofexidine is not a useful adjunct to chlordiazepoxide.
    Alcohol and alcoholism (Oxford, Oxfordshire) 2001;36(5):426-30.
  • 2001: D W Best; J C Harris; M Gossop; V C Manning; L H Man; J Marshall; J Bearn; J Strang
    Are the Twelve Steps more acceptable to drug users than to drinkers? A comparison of experiences of and attitudes to Alcoholics Anonymous (AA) and Narcotics Anonymous (NA) among 200 substance misusers attending inpatient detoxification.
    European addiction research 2001;7(2):69-77.
  • 2001: M Gossop; S Stephens; D Stewart; J Marshall; J Bearn; J Strang
    Health care professionals referred for treatment of alcohol and drug problems.
    Alcohol and alcoholism (Oxford, Oxfordshire) 2001;36(2):160-4.
  • 2000: J Strang; J Marsden; M Cummins; M Farrell; E Finch; M Gossop; D Stewart; S Welch
    Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.
    Addiction (Abingdon, England) 2000;95(11):1631-45.
  • 2000: J Harris; D Best; L H Man; S Welch; M Gossop; J Strang
    Changes in cigarette smoking among alcohol and drug misusers during inpatient detoxification.
    Addiction biology 2000;5(4):443-50.
  • 2000: J Marsden; U Nizzoli; C Corbelli; H Margaron; M Torres; I Prada De Castro; D Stewart; M Gossop
    New European instruments for treatment outcome research: reliability of the maudsley addiction profile and treatment perceptions questionnaire in Italy, Spain and Portugal.
    European addiction research 2000;6(3):115-22.
  • 2000: M Gossop; J Strang
    Price, cost and value of opiate detoxification treatments. Reanalysis of data from two randomised trials.
    The British journal of psychiatry : the journal of mental science 2000;177():262-6.
  • 2000: M Gossop; J Marsden; D Stewart; S Treacy
    Routes of drug administration and multiple drug misuse: regional variations among clients seeking treatment at programmes throughout England.
    Addiction (Abingdon, England) 2000;95(8):1197-206.
  • 2000: M Gossop; J Marsden; D Stewart; A Rolfe
    Patterns of drinking and drinking outcomes among drug misusers. 1-year follow-up results.
    Journal of substance abuse treatment 2000;19(1):45-50.
  • 2000: J Fountain; J Strang; P Griffiths; B Powis; M Gossop
    Measuring met and unmet need of drug misusers: integration of quantitative and qualitative data.
    European addiction research 2000;6(2):97-103.
  • 2000: J Fountain; J Strang; M Gossop; M Farrell; P Griffiths
    Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London.
    Addiction (Abingdon, England) 2000;95(3):393-406.
  • 2000: J Marsden; M Gossop; D Stewart; A Rolfe; M Farrell
    Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study.
    The British journal of psychiatry : the journal of mental science 2000;176():285-9.
  • 1999: M Gossop; J Marsden; D Stewart; A Rolfe
    Treatment retention and 1 year outcomes for residential programmes in England.
    Drug and alcohol dependence 1999;57(2):89-98.
  • 1999: D Best; A Noble; E Finch; M Gossop; C Sidwell; J Strang
    Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment.
    BMJ (Clinical research ed.) 1999;319(7205):290-1.
  • 1999: B Powis; J Strang; P Griffiths; C Taylor; S Williamson; J Fountain; M Gossop
    Self-reported overdose among injecting drug users in London: extent and nature of the problem.
    Addiction (Abingdon, England) 1999;94(4):471-8.
  • 1999: J Strang; B Powis; D Best; L Vingoe; P Griffiths; C Taylor; S Welch; M Gossop
    Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability.
    Addiction (Abingdon, England) 1999;94(2):199-204.
  • 1999: M Gossop; J Marsden; D Stewart; P Lehmann; J Strang
    Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: results from the National Treatment Outcome Research Study.
    The British journal of general practice : the journal of the Royal College of General Practitioners 1999;49(438):31-4.
  • 1999: J Strang; P Griffiths; B Powis; M Gossop
    Heroin chasers and heroin injectors: differences observed in a community sample in London, UK.
    The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 1999;8(2):148-60.
  • 1998: J Marsden; M Gossop; D Stewart; D Best; M Farrell; P Lehmann; C Edwards; J Strang
    The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome.
    Addiction (Abingdon, England) 1998;93(12):1857-67.
  • 1997: D Best; M Gossop; J Marsden; M Farrell; J Strang
    Time of day of methadone consumption and illicit heroin use.
    Drug and alcohol dependence 1997;49(1):49-54.
  • 1997: J Strang; I Marks; S Dawe; J Powell; M Gossop; D Richards; J Gray
    Type of hospital setting and treatment outcome with heroin addicts. Results from a randomised trial.
    The British journal of psychiatry : the journal of mental science 1997;171():335-9.
  • 1997: J Strang; P Griffiths; B Powis; J Abbey; M Gossop
    How constant is an individual's route of heroin administration? Data from treatment and non-treatment samples.
    Drug and alcohol dependence 1997;46(1-2):115-8.
  • 1997: S Williamson; M Gossop; B Powis; P Griffiths; J Fountain; J Strang
    Adverse effects of stimulant drugs in a community sample of drug users.
    Drug and alcohol dependence 1997;44(2-3):87-94.
  • 1997: P Griffiths; M Gossop; S Wickenden; J Dunworth; K Harris; C Lloyd
    A transcultural pattern of drug use: qat (khat) in the UK.
    The British journal of psychiatry : the journal of mental science 1997;170():281-4.
  • 1997: M Gossop; D Best; J Marsden; J Strang
    Test-retest reliability of the Severity of Dependence Scale.
    Addiction (Abingdon, England) 1997;92(3):353.
  • 1996: M Gossop; P Griffiths; B Powis; S Williamson; J Strang
    Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings.
    BMJ (Clinical research ed.) 1996;313(7054):402.
  • 1995: M Gossop
    The treatment mapping survey; a descriptive study of drug and alcohol treatment responses in 23 countries.
    Drug and alcohol dependence 1995;39(1):7-14.
  • 1995: M Gossop; S Darke; P Griffiths; J Hando; B Powis; W Hall; J Strang
    The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users.
    Addiction (Abingdon, England) 1995;90(5):607-14.
  • 1994: M Gossop; B Powis; P Griffiths; J Strang
    Sexual behaviour and its relationship to drug-taking among prostitutes in south London.
    Addiction (Abingdon, England) 1994;89(8):961-70.
  • 1994: M Gossop; J Strang; P Griffiths; B Powis; C Taylor
    A ratio estimation method for determining the prevalence of cocaine use.
    The British journal of psychiatry : the journal of mental science 1994;164(5):676-9.
  • 1994: M Gossop; P Griffiths; B Powis; J Strang
    Cocaine: patterns of use, route of administration, and severity of dependence.
    The British journal of psychiatry : the journal of mental science 1994;164(5):660-4.
  • 1994: P Griffiths; M Gossop; B Powis; J Strang
    Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors.
    Addiction (Abingdon, England) 1994;89(3):301-9.
  • 1994: J Strang; B Powis; P Griffiths; M Gossop
    Heterosexual vaginal and anal intercourse amongst London heroin and cocaine users.
    International journal of STD & AIDS 1994;5(2):133-6.
  • 1993: M Gossop; P Griffiths; B Powis; J Strang
    Severity of heroin dependence and HIV risk. II. Sharing injecting equipment.
    AIDS care 1993;5(2):159-68.
  • 1993: M Gossop; P Griffiths; B Powis; J Strang
    Severity of heroin dependence and HIV risk. I. Sexual behaviour.
    AIDS care 1993;5(2):149-57.
  • 1992: P Griffiths; M Gossop; B Powis; J Strang
    Extent and nature of transitions of route among heroin addicts in treatment--preliminary data from the Drug Transitions Study.
    British journal of addiction 1992;87(3):485-91.
Register to see more